Exploration of the chemical space of benzamide-based voltage-gated potassium channel K_v1.3 inhibitors

1 G. Yellen, The voltage-gated potassium channels and their relatives, Nature 419(6902) (2002) 35–42; https://doi.org/10.1038/nature00978 Search in Google Scholar

2 A. Serrano-Albarrás, I. Estadella, S. Cirera-Rocosa, M. Navarro-Pérez and A. Felipe, Kv1.3: A multi-functional channel with many pathological implications, Expert Opin. Ther. Targets 22(2) (2018) 101–105; https://doi.org/10.1080/14728222.2017.1420170 Search in Google Scholar

3 M. T. Pérez-García, P. Cidad and J. R. López-López, The secret life of ion channels: Kv1.3 potassium channels and proliferation, Am. J. Physiol.-Cell Physiol. 314(1) (2018) C27–C42; https://doi.org/10.1152/ajpcell.00136.2017 Search in Google Scholar

4 H. Wulff and M. Pennington, Targeting effector memory t-cells with Kv1.3 blockers, Curr. Opin. Drug Discov. Devel. 10(4) (2007) 438–445. Search in Google Scholar

5 K. G. Chandy and R. S. Norton, Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease, Curr. Opin. Chem. Biol. 38 (2017) 97–107; https://doi.org/10.1016/j.cbpa.2017.02.015 Search in Google Scholar

6 N. Comes, A. Serrano-Albarrás, J. Capera, C. Serrano-Novillo, E. Condom, S. Ramón Y Cajal, J. C. Ferreres and A. Felipe, Involvement of potassium channels in the progression of cancer to a more malignant phenotype, Biochim. Biophys. Acta BBA - Biomembr. 1848(10) (2015) 2477–2492; https://doi.org/10.1016/j.bbamem.2014.12.008 Search in Google Scholar

7 N. Comes, J. Bielanska, A. Vallejo-Gracia, A. Serrano-Albarrás, L. Marruecos, D. Gómez, C. Soler, E. Condom, S. Ramón Y Cajal, J. Hernández-Losa, J. C. Ferreres and A. Felipe, The voltage-dependent K+ channels Kv1.3 and Kv1.5 in human cancer, Front. Physiol. 4 (2013) Article ID 283 (13 pages); https://doi.org/10.3389/fphys.2013.00283 Search in Google Scholar

8 C. Serrano-Novillo, J. Capera, M. Colomer-Molera, E. Condom, J. Ferreres and A. Felipe, Implication of voltage-gated potassium channels in neoplastic cell proliferation, Cancers 11(3) (2019) Article ID 287 (17 pages); https://doi.org/10.3390/cancers11030287 Search in Google Scholar

9 A. Teisseyre, J. Gąsiorowska and K. Michalak, Voltage-gated potassium channels Kv1.3 – poten-tially new molecular target in cancer diagnostics and therapy, Adv. Clin. Exp. Med. 24(3) (2015) 517–524; https://doi.org/10.17219/acem/22339 Search in Google Scholar

10 M. Pérez-Verdaguer, J. Capera, C. Serrano-Novillo, I. Estadella, D. Sastre and A. Felipe, The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies, Expert Opin. Ther. Targets 20(5) (2016) 577–591; https://doi.org/10.1517/14728222.2016.1112792 Search in Google Scholar

11 A. Schmitz, A. Sankaranarayanan, P. Azam, K. Schmidt-Lassen, D. Homerick, W. Hänsel and H. Wulff, Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases, Mol. Pharmacol. 68(5) (2005) 1254–1270; https://doi.org/10.1124/mol.105.015669 Search in Google Scholar

12 Y. R. Ren, F. Pan, S. Parvez, A. Fleig, C. R. Chong, J. Xu, Y. Dang, J. Zhang, H. Jiang, R. Penner and J. O. Liu, Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes, PLoS one 3(12) (2008) e4009 (11 pages); https://doi.org/10.1371/journal.pone.0004009 Search in Google Scholar

13 W. A. Schmalhofer, J. Bao, O. B. McManus, B. Green, M. Matyskiela, D. Wunderler, R. M. Bugianesi, J. P. Felix, M. Hanner, A.-R. Linde-Arias, C. G. Ponte, L. Velasco, G. Koo, M. J. Staruch, S. Miao, W. H. Parsons, K. Rupprecht, R. S. Slaughter, G. J. Kaczorowski and M. L. Garcia, Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant proper-ties, Biochemistry 41(24) (2002) 7781–7794; https://doi.org/10.1021/bi025722c Search in Google Scholar

14 L. A. Hendrickx, V. Dobričić, Ž. Toplak, S. Peigneur, L. P. Mašič, T. Tomašič and J. Tytgat, Design and characterization of a novel structural class of Kv1.3 inhibitors, Bioorg. Chem. 98 (2020) Article ID 103746 (9 pages). https://doi.org/10.1016/j.bioorg.2020.103746 Search in Google Scholar

15 Š. Gubič, L. A. Hendrickx, X. Shi, Ž. Toplak, Š. Možina, K. M. V. Theemsche, E. L. Pinheiro-Junior, S. Peigneur, A. J. Labro, L. A. Pardo, J. Tytgat, T. Tomašič and L. P. Mašič, Design of new potent and selective thiophene-based KV1.3 inhibitors and their potential for anticancer activity, Cancers 14(11) (2022) Article ID 2595 (20 pages); https://doi.org/10.3390/cancers14112595 Search in Google Scholar

16 Š. Gubič, A. Montalbano, C. Sala, A. Becchetti, L. A. Hendrickx, K. M. Van Theemsche, E. L. Pinheiro-Junior, G. C. Altadonna, S. Peigneur, J. Ilaš, A. J. Labro, L. A. Pardo, J. Tytgat, T. Tomašič, A. Arcangeli and L. Peterlin Mašič, Immunosuppressive effects of new thiophene-based KV1.3 inhibitors, Eur. J. Med. Chem. 259 (2023) Article ID 115561 (17 pages); https://doi.org/10.1016/j.ejmech.2023.115561 Search in Google Scholar